Final Results of a Phase I/II Prospective Dose Escalation Trial Evaluating Safety and Efficacy of Combination 177lu PSMA 617 and NOX66 in Men with End-Stage Metastatic Castration-Resistant Prostate Cancer (lupin Trial).
Journal of Clinical Oncology(2021)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要